Access WallStreet

Merck’s Keytruda Improves PFS in Phase III Lymphoma Study

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Pfizer Inc. (PFE): Free Stock Analysis Report
 
Merck & Co., Inc. (MRK): Free Stock Analysis Report
 
GlaxoSmithKline plc (GSK): Free Stock Analysis Report
 
Amgen Inc. (AMGN): Free Stock Analysis Report
 
To read this article on Zacks.com click here.

< Access WallStreet home

RssEmailTwitterFacebook

Enter your email address to get our headlines in your email!

Delivered by FeedBurner

  • Nothing to display ...
Copyright 1999-2019 Access-WallStreet.com